Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . 国药 集团 SINOPHARM 國藥 控股 股份有限公司 SINOPHARM GROUP CO . LTD . * ( A joint stock limited company incorporated in the People's Republic of China with limited liability and carrying on business in Hong Kong as 國 控 股份有限公司 ) ( Stock Code : 01099 ) ANNOUNCEMENT ON 2026 INTERIM RESULTS The board of directors ( the “ Board ” ) of Sinopharm Group Co. Ltd. ( the “ Company ” or “ Sinopharm Group " ) is pleased to announce the unaudited interim results of the Company and its subsidiaries ( the " Group " ) for the six months ended 30 June 2026 ( the " Reporting Period ” ) together with the comparative figures for the corresponding period of last year as follows : * The Company is registered as a non - Hong Kong company under the Hong Kong Companies Ordinance under its Chinese name and the English name " Sinopharm Group Co. Ltd. " . -1-